+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Infection Drug"

From
From
From
From
From
From
From
From
Hospital Infection Therapeutics Market - Global Forecast 2026-2032 - Product Thumbnail Image

Hospital Infection Therapeutics Market - Global Forecast 2026-2032

  • Report
  • September 2026
  • 188 Pages
  • Global
From
From
From
Cytomegalovirus Treatment Drugs Market - Global Forecast 2026-2032 - Product Thumbnail Image

Cytomegalovirus Treatment Drugs Market - Global Forecast 2026-2032

  • Report
  • September 2026
  • 196 Pages
  • Global
From
Vancomycin Market - Global Forecast 2026-2032 - Product Thumbnail Image

Vancomycin Market - Global Forecast 2026-2032

  • Report
  • September 2026
  • 187 Pages
  • Global
From
From
Onychomycosis Treatment Market - Global Forecast 2026-2032 - Product Thumbnail Image

Onychomycosis Treatment Market - Global Forecast 2026-2032

  • Report
  • September 2026
  • 190 Pages
  • Global
From
Tuberculosis Drugs Market - Global Forecast 2026-2032 - Product Thumbnail Image

Tuberculosis Drugs Market - Global Forecast 2026-2032

  • Report
  • September 2026
  • 196 Pages
  • Global
From
Loading Indicator

The Infectious Diseases Drugs market is a subset of the pharmaceutical industry that focuses on the development and production of drugs used to treat infectious diseases. These drugs are used to treat a wide range of infections, including bacterial, viral, fungal, and parasitic infections. The market is highly competitive, with many companies vying for market share. Companies in the market are typically focused on developing new drugs, as well as improving existing treatments. Additionally, many companies are involved in the production of generic drugs, which are often cheaper than brand-name drugs. Companies in the Infectious Diseases Drugs market include Pfizer, Merck, GlaxoSmithKline, Sanofi, AstraZeneca, Novartis, Johnson & Johnson, and Bristol-Myers Squibb. Show Less Read more